Quantitative assessment of cerebral ventricular volumes in chronic fatigue syndrome.
Lange, G, Holodny, A I, DeLuca, J et al. · Applied neuropsychology · 2001 · DOI
Quick Summary
This study looked at brain scans from people with ME/CFS to measure the size of fluid-filled spaces (ventricles) in their brains. Researchers found that people with ME/CFS had slightly larger ventricles compared to healthy controls, suggesting there may be subtle physical changes in the brains of some ME/CFS patients. While this difference was close to being statistically significant, it provides another piece of evidence that ME/CFS involves measurable brain changes.
Why It Matters
This study provides objective neuroimaging evidence that ME/CFS involves detectable physical changes in brain structure, supporting the biological nature of the disease. Demonstrating quantifiable brain abnormalities helps validate ME/CFS as an organic condition and may guide future research into the mechanisms underlying cognitive and neurological symptoms.
Observed Findings
Lateral ventricular volumes were larger in the CFS group (n=28) compared to controls (n=15)
The difference approached but did not reach statistical significance
Right and left hemisphere subcomponents of the lateral ventricles were measured and compared
No significant asymmetry differences between hemispheres were observed in either group
Subtle structural brain changes were detected using sensitive quantitative volumetric assessment
Inferred Conclusions
Subtle pathophysiological changes in brain structure occur in at least some individuals with CFS
Quantitative assessment methods are more sensitive than previous qualitative approaches for detecting ventricular changes
The pattern of ventricular enlargement is relatively symmetric across hemispheres
Remaining Questions
What causes the ventricular enlargement in CFS patients and what is its functional significance?
Do ventricular volume changes correlate with specific ME/CFS symptoms or disease severity?
Are these ventricular changes present in all ME/CFS patients or only a subset, and what distinguishes these subgroups?
What This Study Does Not Prove
This study does not prove that ventricular enlargement causes ME/CFS symptoms or explain what mechanism produces this change. The findings are correlational and do not establish whether ventricular changes are a primary feature of the disease, a secondary effect, or how they relate to specific symptoms. The small sample and pilot design limit generalizability.